Clinical Cancer Research

Index Medicus: Clin Cancer Res # of Articles: 18

Articles

Telomerase activity in normal and neoplastic breast
  Tsao J-L, Zhao Y, Lukas J, Yang X, Shah A, Press M, and Shibata D
  Yr:1997 Vol:3 Nbr: Pgs: 627-631
  Associated Grant: Biology of Telomere Length Conservation in Breast Cancer
     
Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers
  Krajewki S, Edgerton S, Moore II DH, Krajewska M, and Reed JC
  Yr:1997 Vol:3 Nbr: Pgs: 199-208
  Associated Grant: Bax gene expression in breast cancer
     
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery
  Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, et al.
  Yr:2002 Vol:8 Nbr:4 Pgs: 1172-81
  Associated Grant: Targeted gene therapy using anti-pl85HER2 immunoliposomes
     
The overexpression of RHAMM, a hyaluron-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression
  Wang C, Thor AD, Moore DH, Zhao Y, Kerchmann R, Stern R, Watson PH, and Turley EA
  Yr:1998 Vol:4 Nbr:3 Pgs: 567-576
  Associated Grant: The Breast Tumor Suppressor Function of Hyaluronidase
     
Synthetic analogs of green tea catechins and their in vitro cell growth inhibition activity. Proceedings 199 AACR-NCI-EORTC international Conference, Clin. Cancer Res. 5(S), 3844 (1999).
  Zaveri, Nurulain T. and Chao Wa-Ru
  Yr:1999 Vol:5 Nbr:568 Pgs: 3844
  Associated Grant: Analogs of tea polyphenols for breast cancer chemoprevention
     
The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.
  Shan S, Lockhart AC, Saito WY, Knapp AM, Laderoute KR, Dewhirst MW
  Yr:2001 Vol:7 Nbr:8 Pgs: 2590-96
  Associated Grant: Novel Anti-vascular Agents for Breast Cancer Therapy
     
Development of Tumor-infiltrating Lymphocytes in Breast Cancer after Neoadjuvant Paclitaxel Chemotherapy Clin. Canc. Res. 7:3025-3030
  Demaria S, Volm MD, Shapiro RL, Yee HT, Oratz R, Formenti SC, Muggia F, Symmans WF
  Yr:2001 Vol:7 Nbr:10 Pgs: 3025-30
  Associated Grant: Biologic Determinants of Response to Paclitaxel & Radiation
     
Telomerase activity in normal and neoplastic breast
  Tsang JL, Zhao Y, Lukas J, Yang X, et al.
  Yr:1997 Vol:3 Nbr: Pgs: 627-631
  Associated Grant: USC/Norris Breast Cancer Research Training Program
     
Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomes.
  Drummond DC, Marx C, Guo Z, Scott G, Noble C, Wang D, Pallavicini M, Kirpotin DB, Benz CC
  Yr:2005 Vol:11 Nbr:9 Pgs: 3392-401
  Associated Grant: Enhanced HER-2 Directed Liposomal Therapeutics
     
Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
  Namba R, et al, and Gregg JP
  Yr:2006 Vol:12 Nbr:8 Pgs: 2613-2621
  Associated Grant: Targeted Chemoprevention in a Mouse Model for DCIS
     
Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
  Namba R, Young LJ, et al. and , MacLeod CL, and Gregg JP
  Yr:2006 Vol:12 Nbr:8 Pgs: 2613-21
  Associated Grant: Molecular Analysis of DCIS Progression in a Mouse Model
     
The biology of metastasis to a sanctuary site.
  Palmieri D, Chambers AF, Felding-Habermann B, Huang S, Steeg PS.
  Yr:2007 Vol:13 Nbr:6 Pgs: 1656-62
  Associated Grant: Stem Cells in Breast Cancer Metastasis
     
The biology of metastasis to a sanctuary site.
  Palmieri D, Chambers AF, Felding-Habermann B, Huang S, Steeg PS.
  Yr:2007 Vol:13 Nbr:6 Pgs: 1656-62
  Associated Grant: Inhibition of Brain Metastases in Breast Cancer
     
Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
  Namba R, et al , Borowsky AD, Qi J, Tepper CG, MacLeod CL, Cardiff RD, Gregg JP.
  Yr:2006 Vol:12 Nbr:8 Pgs: 2613-21
  Associated Grant: Defining Mammary Cancer Origins in a Mouse Model of DCIS
     
The macrophage colony-stimulating factor 1 response signature in breast carcinoma.
  Beck AH, Espinosa I, Edris B, Li R, Montgomery K, and West RB
  Yr:2009 Vol:15 Nbr:3 Pgs: 778-87
  Associated Grant: Determination of Stromal Gene Expression in Breast Cancer
     
Phosphorylation of the SRC epithelial substrate Trask is tightly regulated in normal epithelia but widespread in many human epithelial cancers.
  Wong CH, Baehner FL, et al, and Moasser MM
  Yr:2009 Vol:15 Nbr:7 Pgs: 2311-22
  Associated Grant: Trask, a Candidate Breast Cancer Metastasis Protein
     
Endogenous versus tumor-specific host response to breast carcinoma: a study of stromal response in synchronous breast primaries and biopsy site changes.
  Wu J, Beck A, Pate L, Witten D, Zhu S, Montgomery K, Allison K, van de Rijn M, West RB
  Yr:2011 Vol:17 Nbr:3 Pgs: 437-46
  Associated Grant: Stroma Expression Patterns in Breast Cancer
     
Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications DOI: 10.1158/1078-0432.CCR-16-0028
  Andrew R. Chin, Shizhen Emily Wang
  Yr:2016 Vol: Nbr: Pgs:
  Associated Grant: Systemic metabolic reprogramming by BC-secreted microRNAs